Risultati per 'Biolegend':
Di seguito l'elenco dei risultati di ricerca trovati rilevanti per la keyword 'Biolegend':
Risultati maggiormente rilevanti:
biolegend | your partner for antibodies, proteins, kits ...
BioLegend provides IVD reagents for immunohistochemistry and ASR* products for immunophenotyping. Our IVD and ASR products are manufactured and tested to meet the high quality that clinical laboratories have come to expect. We are committed to providing growing portfolios of products with superior value as well as excellent service and support.
biolegendBioLegend is proud to have been with you on your journey to make discoveries happen in. cancer therapy, neuroscience, and immunology. Our research partners’ success is our success, both as a company and as humans working together for a better future. ABOUT US.
biolegend / ricerca scientifica / campoverdeAziende BioLegend. BioLegend è un’azienda all’avanguardia nello sviluppo di nuovi anticorpi e reagenti per ricerca. Con instancabile dedizione BioLegend promuove il progresso scientifico e la ricerca fornendo prodotti di altissima qualità al miglior prezzo, supporto tecnico qualificato e tutela del cliente.
Altri risultati:
biolegend - wikipediaBioLegend is a global developer and manufacturer of antibodies and reagents used in biomedical research located in San Diego, California. It was incorporated in June 2002 and has since expanded to include BioLegend Japan KK, where it is partnered with Tomy Digital Biology Co., Ltd. in Tokyo, BioLegend Europe in the United Kingdom, BioLegend GmbH in Germany, and BioLegend UK Ltd in the United ...
ce3d™ tissue clearing - biolegendCe3D™ Tissue Clearing Solution reduces light scattering by normalizing the refractive index in tissue samples, making them transparent and ideal for the generation of mesmerizing 3D images in multicolor fluorescence microscopy applications.
perkinelmer buys biolegend for $5.25 billion in cash, stockPerkinElmer Buys BioLegend for $5.25 Billion in Cash, Stock. (Bloomberg) -- PerkinElmer Inc. agreed to buy BioLegend, a privately held maker of biomedical research tools for Covid-19 and other illnesses, for about $5.25 billion in shares and cash.
perkinelmer buys biolegend for $5.25 billion in cash, stockPerkinElmer Inc. agreed to buy BioLegend, a privately held maker of biomedical research tools for Covid-19 and other illnesses, for about $5.25 billion in shares and cash.